Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Artresan
- Development stage
- Unknown
- Lead developer
- USP Zdrowie
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Artresan is a line of joint health products developed by USP Zdrowie, a leading consumer health company in Poland. The brand encompasses several formulations, including dietary supplements and over-the-counter (OTC) products, designed to support the maintenance of healthy joint cartilage and improve mobility. The primary active ingredient in the standard Artresan formulation is glucosamine sulfate, a naturally occurring amino sugar that acts as a precursor for the synthesis of glycosaminoglycans, which are essential for cartilage repair and maintenance. The Artresan Optima variant includes a combination of glucosamine, chondroitin sulfate, and a MEDIflex complex consisting of botanical extracts (ginger, turmeric, rosehip) and Vitamin C to provide anti-inflammatory support and promote collagen production. The Artresan Efekt variant features ApresFlex, a standardized extract of Boswellia serrata that inhibits the 5-lipoxygenase (5-LOX) enzyme, thereby reducing the production of pro-inflammatory leukotrienes and providing rapid relief from joint discomfort.
- Brand names
- ArtresanArtresan OptimaArtresan EfektArtresan 1 a DayArtresan1 a DayArtresan-1 a Day
- Other names
- glucosamine sulfate
02
Targets
ALOX5 (Arachidonate 5-lipoxygenase)
Beyond the preview
Go deeper on Artresan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Artresan.